You are in: eMedicine Specialties > Urology > Infections and Related Inflammatory Conditions PyonephrosisArticle Last Updated: Sep 14, 2006AUTHOR AND EDITOR INFORMATIONAuthor: Andrew C Peterson, MD, FACS, Assistant Professor of Surgery, Uniformed Services University; Chief, Reconstructive Urology, Female Urology and Urodynamics, Residency Program Director, Department of Surgery, Section of Urology, Madigan Army Medical Center Andrew C Peterson is a member of the following medical societies: American College of Surgeons, American Urological Association, and Western Section American Urological Association Editors: Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Shlomo Raz, MD, Professor, Department of Surgery, Division of Urology, University of California at Los Angeles School of Medicine; J Stuart Wolf, Jr, MD, FACS, David A Bloom Professor of Urology, Director, Division of Minimally Invasive Urology, Department of Urology, University of Michigan Medical Center; Stephen W Leslie, MD, FACS, Founder and Medical Director of the Lorain Kidney Stone Research Center, Clinical Assistant Professor, Department of Urology, Medical College of Ohio Author and Editor Disclosure Synonyms and related keywords: infected hydronephrosis, urinary tract infection, UTI, infected purulent urine, obstructed collecting system, urinary tract obstruction, urinary obstruction, infections of the kidney, urosepsis, nephropyosis, pyelonephritis, septic shock, diabetes mellitus, kidney stones, ureteropelvic junction obstruction, pelvic kidney, horseshoe kidney, xanthogranulomatous pyelonephritis, Escherichia coli, E coli, Enterococcus species, Candida species, Enterobacter species, Klebsiella species, Proteus species, Pseudomonas species, Bacteroides species, Staphylococcus species, Salmonella species, tuberculosis, staghorn calculi, fungus balls, metastatic retroperitoneal fibrosis, renal tumors, testicular cancer, colon cancer, obstructing transitional cell carcinoma, UPJ obstruction, obstructing ureterocele, ureterovesical junction obstruction, chronic stasis of urine, neurogenic bladder, ureteralstrictures INTRODUCTIONPyonephrosis refers to infected purulent urine in an obstructed collecting system. Similar to an abscess, it is typically associated with fever, chills, and flank pain, although some patients may be asymptomatic. Pyonephrosis may develop from a broad spectrum of pathologic conditions involving either an ascending infection of the urinary tract or the hematogenous spread of a bacterial pathogen. Urinary obstruction in the presence of pyelonephritis may lead to a collection of WBCs, bacteria, and debris in the collecting system and subsequently result in pyonephrosis. In this situation, with the accompanying "pus under pressure," patients may deteriorate rapidly and become septic. Thus, early recognition and treatment of acute infections of the kidney, especially in patients with suspected urinary tract obstruction, are of paramount importance. ProblemIf not recognized early, patients with pyonephrosis may rapidly deteriorate and develop septic shock. In addition to the morbidity and mortality of septic shock, potential complications of delayed diagnosis and treatment include irreversible damage to the kidneys with possible need for nephrectomy. Even in the modern era of antibiotics, adequately controlling an overwhelming infection in an obstructed renal unit without surgical intervention may be impossible. If the diagnosis is delayed unduly, death may result. FrequencyThis disorder is relatively uncommon, and the true incidence of development with other renal infections is not reported; however, it can commonly occur in patients with upper urinary tract obstruction from a variety of causes (eg, stones, tumors, ureteropelvic junction [UPJ] obstruction). EtiologyUpper urinary tract infection in combination with obstruction and hydronephrosis may lead to pyonephrosis. This may progress to renal and perirenal abscesses. Risk factors for developing pyonephrosis include immunosuppression from medications (eg, steroids), disease (eg, diabetes mellitus, AIDS), and any anatomic urinary tract obstruction (eg, stones, tumors, UPJ obstruction, pelvic kidney, horseshoe kidney). Fungal infections are commonly associated with patients who are immunocompromised or those treated with long-term antibiotics. When fungus balls are present, they may obstruct the renal pelvis or the ureter, resulting in pyonephrosis. Xanthogranulomatous pyelonephritis, a clinical condition consisting of upper renal calculus and infection, has been reported to progress to pyonephrosis when obstruction is present. Pyonephrosis is uncommon in adults, rare in children, and thought to be extremely rare in neonates. Recently, however, pyonephrosis has been reported in several neonates as well as adults, making clear that pyonephrosis may develop in any age group. The disease process of pyonephrosis consists of 2 parts: infection and obstruction. Infection Multiple infectious agents are reported in the current literature. These include the following in decreasing order of incidence:
Obstruction The etiology of the obstruction may relate to any of the following factors:
PathophysiologyPurulent exudate collects in a hydronephrotic collecting system and forms an abscess. This purulent exudate consists of inflammatory cells, infectious organisms, and a necrotic sloughed urothelium. This becomes walled off and protected from the body's natural immune system and antibiotics. If not recognized and treated promptly, this infectious process may progress, often resulting in clinical deterioration of the patient with urosepsis, which can occur swiftly. ClinicalPatients with pyonephrosis may present with clinical symptoms ranging from asymptomatic bacteruria (15%) to frank sepsis. Maintain a high index of suspicion when examining a patient with a history of fever, flank pain, evidence of a urinary tract infection, and obstruction or hydronephrosis. On physical examination, a palpable abdominal mass may be associated with the hydronephrotic kidney. INDICATIONSThe presence of pyonephrosis is a surgical emergency and needs immediate intervention. Pyonephrosis may be treated with either an antegrade or a retrograde decompression. An indication for retrograde decompression, or placement of a ureteral stent, is a stable patient with no signs of hemodynamic instability. Intravenous antibiotics must be given prior to stent placement in a stable patient; after this is done, retrograde decompression may be safely undertaken. Disadvantages of retrograde decompression include lack of antegrade access for radiologic studies, smaller-caliber urinary drainage catheter than with percutaneous access, increased irritative urinary symptoms, inability to administer medications such as antibiotics via nephrostomy tube, and limitation of percutaneous chemolysis that may cause dissolution of any stones. To maximize drainage, a urethral catheter should be left in place after stent placement. A retrograde approach usually requires a general anesthetic, and bypassing the obstruction may not be possible in some patients. In addition, the risk of pyelovenous, pyelolymphatic, and pyelosinus backflow of infected urine into the systemic circulatory system always exists with retrograde manipulation. This may result in iatrogenic sepsis and patient decompensation. Definitive management of stones and obstruction with ureteroscopy, lithotripsy, or endopyelotomy is contraindicated in the immediate treatment of patients with pyonephrosis. If retrograde stent placement is chosen, the surgeon should attempt to minimize instrumentation and retrograde pyelography as much as possible and decompress the obstruction with minimal trauma to the urinary tract. Recently, reports exist of ureteroscopic instrumentation involving stone and obstruction removal during active infection. Although performed at some institutions, the authors do not recommend this practice because it may result in sepsis and worsening infection. Antegrade treatment with percutaneous nephrostomy tube placement is indicated in any patient with hemodynamic instability or sepsis and when retrograde instrumentation may cause an inappropriate delay in treatment or unnecessary trauma to the genitourinary tract. While some believe this technique to be more invasive, placement of a nephrostomy tube has certain advantages. It allows administration of medication to treat difficult infections directly to the collecting system and ureter, stones may sometimes be dissolved chemically with antegrade irrigation, and it allows antegrade treatment of obstructing stones. Antegrade radiographic studies often help with treatment planning once the patient is stable. Most importantly, it allows drainage of an infected renal unit with minimal trauma or risk to the patient, and it avoids the additional risks of a general anesthetic. Disadvantages to nephrostomy tube placement include the possibility of renal trauma and difficulties in placing the tube in some patients because of body habitus or mild hydronephrosis that makes localization with ultrasonography difficult. With pyonephrosis, nephrostomy tubes should never be placed transpleurally. This avoids pneumothorax, pleural infections, and empyema formation. Percutaneous suprapubic tube placement guided by ultrasonography or radiography can be helpful in selected patients with urosepsis due to bladder outlet obstruction when a Foley catheter cannot be easily placed. RELEVANT ANATOMYSee Pathophysiology. CONTRAINDICATIONSRetrograde placement of a ureteral stent is contraindicated in an unstable patient with sepsis. In these situations, proceeding directly with percutaneous placement of a nephrostomy tube is best for maximal decompression of the infected system. The retrograde stent placement is relatively contraindicated in patients with known impacted and obstructing upper tract stones that may ultimately need percutaneous treatment or in those with fungus balls that may need additional therapy with antegrade irrigation and instrumentation. WORKUPLab Studies
Imaging Studies
Other Tests
Diagnostic Procedures
TREATMENTMedical therapyThe treatment of pyonephrosis has changed dramatically over the years. Prior to the 1980s, emergency surgical excision with nephrectomy was the standard of care. However, this was associated with a high morbidity and complication rate, including sepsis, wound infections, peritonitis, and fistulas. Initially, treat patients with appropriate intravenous antibiotics consisting of an aminoglycoside (gentamicin) and gram-positive coverage (ampicillin) prior to instrumentation. Depending on the clinical situation, additional anaerobic coverage with clindamycin may be needed. Be cognizant of the fact that patients may have fungal infection or tuberculosis. The use of antifungal or antibacterial agents is predicated upon culture results. Many patients are septic and may require aggressive fluid resuscitation with crystalloids. Pressor support (with dopamine) may be needed to maintain adequate blood pressure and hemodynamics. Surgical therapyWith the advent of ultrasonography and CT scanning, percutaneous drainage has become the mainstay of treatment. It has low morbidity and mortality rates with an excellent outcome. CT- and ultrasound-guided drainage significantly decreases the need for nephrectomy, resulting in renal preservation. Retrograde decompression of pyonephrosis in patients who are severely ill is not advocated because of the need for internal instrumentation and the possible future need for antegrade irrigation. In selected healthy stable patients, consider retrograde decompression as an option. This avoids placement of the percutaneous nephrostomy tube and allows internalization of the drainage catheter; however, it does not allow for antegrade medication infusion or treatment of obstruction that is sometimes needed with funguria and infected stones. Consider treating these patients in the following 2 stages:
COMPLICATIONSMost patients do well after prompt diagnosis and treatment. Sepsis is the most common complication in the perioperative period when treatment is delayed. Generalized peritonitis can result from a rupture of the pyonephrotic kidney. In 1996, Hendaoui et al reported the first case of a splenic abscess that developed from a ruptured pyonephrosis after the development of generalized peritonitis. This occurrence was again reported by Sugiura et al in 2004, making it possibly much more common than originally thought. Fistulas may develop and can be associated with peritonitis. Renocolonic, renoduodenal, and renocutaneous fistulas are the most common; therefore, suspect these in patients with continued electrolyte disorders, diarrhea, and recurrent urinary tract infections after resolution of pyonephrosis. Other rare complications include pneumoperitoneum from lithogenic pyonephrosis, nephrobronchial fistula, renal vein thrombosis, psoas abscess and/or perinephric abscess, and rhabdomyolysis. Delay in diagnosis and treatment may result in a loss of renal function from parenchymal damage. Perinephric hematomas, blood transfusions, and the need for nephrostomy tube revision are also complications of percutaneous drainage. If a nephrectomy must be performed in the future, long-term nephrostomy tubes are reported to increase the risk of a postoperative wound infection. OUTCOME AND PROGNOSISMost infectious processes resolve within 24-48 hours and significantly improve after either nephrostomy or retrograde stent drainage of the infection. If pyonephrosis is recognized and treated promptly, recovery of the affected renal unit is rapid. Long-term complications are rare when managed promptly; however, injury to the functional renal unit, abscesses, fistulas, and scarring may occur when definitive therapy is delayed. For excellent patient education resources, visit eMedicine's Kidneys and Urinary System Center. Also, see eMedicine's patient education article Urinary Tract Infections. FUTURE AND CONTROVERSIESTreatment of infections occurring from pyelonephritis and pyonephrosis are changing rapidly and dramatically. The persistent use of broad-spectrum antibiotics, an increase in the population of immunocompromised patients (eg, patients with AIDS, patients undergoing chemotherapy), and the evolution of multiple drug–resistant bacteria complicate the picture. Rare organisms, multiple organism infections, and Candida species now are commonly associated with infected calculi. Antegrade percutaneous nephrostomy placement allows both drainage of purulent material and the antegrade infusion of antifungal medication and antibiotics to adequately treat these infections. Retrograde stent placement does not allow this form of therapy; therefore, many experts stress the importance of nephrostomy drainage rather than retrograde transurethral drainage for pyonephrosis. The authors currently prefer retrograde, stent drainage after loading the patient with broad-spectrum antibiotics, saving antegrade drainage for the patients that may require further intervention, as discussed above. The need for nephrectomy after percutaneous nephrostomy drainage and antibiotic treatment is debated. Some advocate the need for removal if the source of obstruction is not clearly identified. This can help exclude the presence of a malignant etiology for the obstruction, such as transitional cell carcinoma of the renal pelvis. Nonresponsiveness to therapy and progression of disease after percutaneous drainage are additional indications for nephrectomy; however, current technology reflects that preserving the maximal number of renal units is prudent. MULTIMEDIA
REFERENCES
Article Last Updated: Sep 14, 2006 | ||||||||||||||